Abstract
A series of strained Ru(II) complexes were studied for potential anticancer activity in hypoxic tissues. The complexes were constructed with methylated ligands that were photolabile and an imidizo[4,5-f][1,10]phenanthroline ligand that contained an appended aromatic group to potentially allow for contributions of ligand-centered excited states. A systematic variation of the size and energy of the aromatic group was performed using systems containing 1–4 fused rings, and the photochemical and photobiological behaviors of all complexes were assessed. The structure and nature of the aromatic group had a subtle impact on photochemistry, altering environmental sensitivity, and had a significant impact on cellular cytotoxicity and photobiology. Up to 5-fold differences in cytotoxicity were observed in the absence of light activation; this rose to 50-fold differences upon exposure to 453 nm light. Most significantly, one complex retained activity under conditions with 1% O2, which is used to induce hypoxic changes. This system exhibited a photocytotoxicity index (PI) of 15, which is in marked contrast to most other Ru(II) complexes, including those designed for O2-independent mechanisms of action.
| Original language | English |
|---|---|
| Pages (from-to) | 327-339 |
| Number of pages | 13 |
| Journal | Photochemistry and Photobiology |
| Volume | 96 |
| Issue number | 2 |
| DOIs | |
| State | Published - Mar 1 2020 |
Bibliographical note
Publisher Copyright:© 2019 American Society for Photobiology
Funding
Research reported in this publication was supported by the National Cancer Institute (NCI) of the National Institutes of Health (NIH) under Award Number R01CA222227 (to SAM) and the National Institute of General Medical Sciences (NIGMS) of the NIH under Award Number R01GM107586 (to ECG). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. We also acknowledge financial support from the University of North Carolina at Greensboro, the Natural Sciences and Engineering Council of Canada, the Canadian Institutes of Health Research, the Canadian Foundation for Innovation, the Nova Scotia Research and Innovation Trust, and Acadia University. Research reported in this publication was supported by the National Cancer Institute (NCI) of the National Institutes of Health (NIH) under Award Number R01CA222227 (to SAM) and the National Institute of General Medical Sciences (NIGMS) of the NIH under Award Number R01GM107586 (to ECG). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. We also acknowledge financial support from the University of North Carolina at Greensboro, the Natural Sciences and Engineering Council of Canada, the Canadian Institutes of Health Research, the Canadian Foundation for Innovation, the Nova Scotia Research and Innovation Trust, and Acadia University.
| Funders | Funder number |
|---|---|
| Canadian Foundation for Innovation | |
| National Institutes of Health (NIH) | |
| National Childhood Cancer Registry – National Cancer Institute | R01CA222227 |
| National Institute of General Medical Sciences | R01GM107586 |
| University of North Carolina and North Carolina State University | |
| Acadia University | |
| Nova Scotia Research Innovation Trust | |
| University of North Carolina, Greensboro | |
| Canadian Institutes of Health Research | |
| Natural Sciences and Engineering Research Council of Canada | |
| Canada Foundation for Innovation |
ASJC Scopus subject areas
- Biochemistry
- Physical and Theoretical Chemistry
Fingerprint
Dive into the research topics of 'Strained, Photoejecting Ru(II) Complexes that are Cytotoxic Under Hypoxic Conditions'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver